AJOVY™, Teva’s new migraine drug gets USFDA approval
Just four months after Aimovig™ (erenumab), codeveloped by Amgen and Novartis, the migraine community rejoices in the approval of yet another injectable migraine drug. By Rajaneesh K Gopinath Migraine is …
Read More